To gain insights into the mechanistic basis for the MTA1 upregulation in Pten loss-driven prostate tumorigenesis and tumor progression, we studied the effects of MTA1 knockdown in the human prostate cancer cell lines, LNCaP and DU145. This evidence concerns the gene MTA1 and prostate carcinoma.